What is he best known for?
The fields of study he is best known for:
- Organic chemistry
- Stereochemistry
- Enzyme
Jun'ichi Kobayashi focuses on Stereochemistry, Sponge, Alkaloid, Biochemistry and Tunicate.
His study on Stereochemistry is mostly dedicated to connecting different topics, such as Organic chemistry.
In his study, which falls under the umbrella issue of Sponge, Leukemia L1210 is strongly linked to Cytotoxic T cell.
The concepts of his Alkaloid study are interwoven with issues in Lycopodium, Moiety, Two-dimensional nuclear magnetic resonance spectroscopy and Biological activity, Pharmacognosy.
His work carried out in the field of Biochemistry brings together such families of science as Biophysics and Calcium.
As a part of the same scientific family, Jun'ichi Kobayashi mostly works in the field of Tunicate, focusing on Calmodulin and, on occasion, Derivative.
His most cited work include:
- Absolute stereochemistry of citrinadins a and B from marine-derived fungus. (151 citations)
- The Daphniphyllum alkaloids (146 citations)
- Alteramide A, a new tetracyclic alkaloid from a bacterium Alteromonas sp. associated with the marine sponge Halichondria okadai (132 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Stereochemistry, Sponge, Alkaloid, Organic chemistry and Dinoflagellate.
Jun'ichi Kobayashi frequently studies issues relating to Ring and Stereochemistry.
His study in the field of Agelas and Amphimedon also crosses realms of Animal origin and Spectral data.
His studies deal with areas such as Biological activity, Pharmacognosy and Piperidine as well as Alkaloid.
His study in Dinoflagellate concentrates on Amphidinium sp. and Amphidinium.
Jun'ichi Kobayashi studies Lycopodium, focusing on Lycopodium alkaloid in particular.
He most often published in these fields:
- Stereochemistry (77.10%)
- Sponge (32.32%)
- Alkaloid (18.86%)
What were the highlights of his more recent work (between 2010-2020)?
- Stereochemistry (77.10%)
- Sponge (32.32%)
- Antimicrobial (4.55%)
In recent papers he was focusing on the following fields of study:
Jun'ichi Kobayashi spends much of his time researching Stereochemistry, Sponge, Antimicrobial, Moiety and Agelas.
Jun'ichi Kobayashi is studying Alkaloid, which is a component of Stereochemistry.
In general Sponge, his work in Amphimedon is often linked to Spectral data linking many areas of study.
As a member of one scientific family, he mostly works in the field of Antimicrobial, focusing on Bacteria and, on occasion, Amphidinolide Q.
His Moiety research focuses on Amide and how it relates to Hemiaminal, Lycopodium alkaloid, Cycloheptene and Lycopodium.
He has included themes like Diastereomer and Diterpene in his Agelas study.
Between 2010 and 2020, his most popular works were:
- Lyconadins D and E, and complanadine E, new Lycopodium alkaloids from Lycopodium complanatum (41 citations)
- Hyrtimomines A-C, new heteroaromatic alkaloids from a sponge Hyrtios sp. (35 citations)
- Lyconadins C and F, new Lycopodium alkaloids from Lycopodium complanatum (34 citations)
In his most recent research, the most cited papers focused on:
- Organic chemistry
- Stereochemistry
- Enzyme
The scientist’s investigation covers issues in Stereochemistry, Sponge, Antimicrobial, Alkaloid and Ring.
In general Stereochemistry study, his work on Moiety often relates to the realm of Spectral data, thereby connecting several areas of interest.
Jun'ichi Kobayashi has researched Moiety in several fields, including Biological activity, Lycopodium and Amide.
All of his Sponge and Agelas and Amphimedon investigations are sub-components of the entire Sponge study.
The Antimicrobial study combines topics in areas such as Dinoflagellate, Micrococcus luteus, Glycoside, Candida albicans and Bacteria.
His Ring research is multidisciplinary, incorporating elements of Indole test, Marine sponges and L1210 cells.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
